TrialNet Locations

With more than 200 locations offering Pathway to Prevention screening and the option to get a test kit in the mail to take to a local lab, it’s easy to participate. These Centers coordinate all the TrialNet sites in their geographical region.

Find a Location

from

United Kingdom

University of Bristol

Bristol, GB

The University of Bristol is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Polly Bingley, MD, the TrialNet team at University of Bristol is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Finland

University of Helsinki

Pediatric Research Center Endocrinology and Diabetology

Helsinki, FI

University of Helsinki is one of the 25 Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Professor Mikael Knip, the TrialNet team at the University of Helsinki is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Germany

Institute of Diabetes Research

Helmholtz Zentrum München

Neuherberg, DE

Institute of Diabetes Research is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Prof. Anette Ziegler, the TrialNet team at the Institute of Diabetes Research is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Canada

The Hospital for Sick Children

Toronto, ON

The Hospital for Sick Children (SickKids) is one of twenty-five type 1 diabetes TrialNet International Clinical Centres at the forefront of type 1 diabetes research. Led by Diane Wherrett, MD, the TrialNet team at SickKids is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Australia

Baker Heart and Diabetes Institute

Melbourne, VIC

Led by A/Prof Neale Cohen, the TrialNet team at Baker Heart and Diabetes Institute is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Canberra Hospital Paediatric Research

Canberra, ACT

Led by Dr. Tony Lafferty, the TrialNet team at Canberra Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Hunter Diabetes Centre

Newcastle, NSW

Led by Dr. Claire Morbey, the TrialNet team at Hunter Diabetes Centre is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

John Hunter Hospital Department of Diabetes and Endocrinology

Newcastle, NSW

Led by Dr. Shamasunder Acharya, the TrialNet team at John Hunter Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Mater Medical Research Institute

Queensland Diabetes Centre

Brisbane, QLD

Led by Dr. Andrew Cotterill, the TrialNet team at Mater Medical Research Institute is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Monash Medical Centre

Melbourne, VIC

Led by Dr Philip Bergman, the TrialNet team at Monash Medical Centre is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Pages